ATE493139T1 - Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen - Google Patents

Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen

Info

Publication number
ATE493139T1
ATE493139T1 AT05024278T AT05024278T ATE493139T1 AT E493139 T1 ATE493139 T1 AT E493139T1 AT 05024278 T AT05024278 T AT 05024278T AT 05024278 T AT05024278 T AT 05024278T AT E493139 T1 ATE493139 T1 AT E493139T1
Authority
AT
Austria
Prior art keywords
prevent
microbial infections
surface use
control microbial
bacillus spores
Prior art date
Application number
AT05024278T
Other languages
German (de)
English (en)
Inventor
Sean Farmer
Original Assignee
Ganeden Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ganeden Biotech Inc filed Critical Ganeden Biotech Inc
Application granted granted Critical
Publication of ATE493139T1 publication Critical patent/ATE493139T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A01N63/22—Bacillus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Pest Control & Pesticides (AREA)
  • Wood Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Inorganic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05024278T 1997-04-18 1998-04-10 Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen ATE493139T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4464397P 1997-04-18 1997-04-18

Publications (1)

Publication Number Publication Date
ATE493139T1 true ATE493139T1 (de) 2011-01-15

Family

ID=21933508

Family Applications (2)

Application Number Title Priority Date Filing Date
AT05024278T ATE493139T1 (de) 1997-04-18 1998-04-10 Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
AT98918115T ATE308987T1 (de) 1997-04-18 1998-04-10 Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT98918115T ATE308987T1 (de) 1997-04-18 1998-04-10 Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen

Country Status (9)

Country Link
US (2) US20090186057A1 (enExample)
EP (2) EP1629846B1 (enExample)
JP (2) JP4678896B2 (enExample)
AT (2) ATE493139T1 (enExample)
AU (1) AU749001B2 (enExample)
CA (1) CA2287451C (enExample)
DE (2) DE69842080D1 (enExample)
ES (1) ES2255730T3 (enExample)
WO (1) WO1998047374A1 (enExample)

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020959C1 (ru) * 1991-10-21 1994-10-15 Игорь Дмитриевич Поляков Вакцина поливак-тм для профилактики и лечения дерматофитозов животных
US6716435B1 (en) 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US8563522B2 (en) 1997-07-08 2013-10-22 The Iams Company Method of maintaining and/or attenuating a decline in quality of life
US7767203B2 (en) 1998-08-07 2010-08-03 Ganeden Biotech, Inc. Methods for the dietary management of irritable bowel syndrome and carbohydrate malabsorption
CA2368509A1 (en) * 1999-04-14 2000-10-19 Ganeden Biotech, Inc. Methods for inhibiting microbial infections associated with sanitary products
US6264967B1 (en) * 1999-07-14 2001-07-24 Shinei Fermentec Corporation Method for eliminating Staphylococcus aureus, novel microorganism of genus Brachybacterium, and care garment, care sheet or care bedclothes, each being immobilized with microorganism of genus Brachybacterium
WO2001013956A2 (en) 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications
AU783905B2 (en) * 1999-08-26 2005-12-22 Ganeden Biotech, Inc. Use of emu oil carrier for antifungal, antibacterial, and antiviral medications
JP2003513649A (ja) * 1999-11-08 2003-04-15 ガネデン バイオテック， インコーポレイテッド Ｂａｃｉｌｌｕｓｃｏａｇｕｌａｎｓによる病原体の阻害
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
US6967025B2 (en) * 2000-01-18 2005-11-22 The Procter & Gamble Company Articles with spores exhibiting antagonistic properties against pathogens and/or spores forming micro-organisms
EP1118342A1 (en) * 2000-01-18 2001-07-25 The Procter & Gamble Company Articles comprising a spore-forming lactic acid-producing micro-organism
EP1118343A1 (en) * 2000-01-18 2001-07-25 The Procter & Gamble Company Articles with spores exhibiting antagonistic properties against pathogens
WO2001052913A1 (en) * 2000-01-18 2001-07-26 The Procter & Gamble Company Articles with spores exhibiting antagonistic properties against pathogens and/or spores forming micro-organisms
SE518097C2 (sv) 2000-10-03 2002-08-27 Ellen Ab Förfarande för framställning av en absorberande sanitetsartikel som innefattar mjölksyraproducerande bakterier samt sådant alster
JP2002113041A (ja) 2000-10-11 2002-04-16 Uni Charm Corp 皮膚常在菌をコントロールする吸収性物品
EP1432459A1 (en) * 2001-10-02 2004-06-30 Kimberly-Clark Worldwide, Inc. Inhibition of exoprotein production using aromatic compositions
US20030143262A1 (en) 2001-12-13 2003-07-31 Brusk Ulla Forsgren Hygiene tissue
SE0104199L (sv) * 2001-12-13 2003-06-14 Sca Hygiene Prod Ab Ny produkt
ITMI20030643A1 (it) 2003-04-01 2004-10-02 Copan Innovation Ltd Tampone per il prelievo di campioni biologici
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US7785635B1 (en) 2003-12-19 2010-08-31 The Procter & Gamble Company Methods of use of probiotic lactobacilli for companion animals
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US8894991B2 (en) 2003-12-19 2014-11-25 The Iams Company Canine probiotic Lactobacilli
US20050152884A1 (en) 2003-12-19 2005-07-14 The Procter & Gamble Company Canine probiotic Bifidobacteria globosum
JP2005299025A (ja) * 2004-04-13 2005-10-27 Nami Kazuji 抗ウイルス性バイオシート繊維体
US8110215B2 (en) * 2004-04-30 2012-02-07 Kimberly-Clark Worldwide, Inc. Personal care products and methods for inhibiting the adherence of flora to skin
US7854927B2 (en) * 2004-05-11 2010-12-21 Ganeden Biotech, Inc. Methods and compositions for the dietary management of autoimmune disorders
WO2006076780A1 (en) * 2004-12-17 2006-07-27 Gielen Cornelis Use of non-pathogenic bacterial strains in cleaning and milking an animal
WO2006130188A1 (en) 2005-05-31 2006-12-07 The Iams Company Feline probiotic bifidobacteria
DK1880001T3 (da) 2005-05-31 2011-09-12 Iams Company Feline probiotiske lactobacilli
AU2007284126B2 (en) 2006-08-11 2013-12-19 Novozymes Biologicals, Inc. Bacteria cultures and compositions comprising bacteria cultures
WO2008060200A1 (en) * 2006-11-17 2008-05-22 Sca Hygiene Products Ab Sanitary article comprising a microbe-inhibiting composition
WO2008074331A1 (en) * 2006-12-19 2008-06-26 Ferrosan A/S Wound or tissue dressing comprising lactic acid bacteria
CN101711158A (zh) 2007-02-01 2010-05-19 爱默思公司 使用葡萄糖抗代谢物、鳄梨或鳄梨提取物减轻哺乳动物炎症和应激反应的方法
WO2008109182A1 (en) * 2007-03-07 2008-09-12 Grune Guerry L Sunblock formulations
TW200904340A (en) 2007-05-11 2009-02-01 Mannatech Inc Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
GB0714338D0 (en) * 2007-07-23 2007-09-05 Sinclair Pharmaceuticals Ltd method
AU2008293896B2 (en) 2007-08-29 2014-10-02 Ganeden Biotech, Inc. Baked goods
FR2930443B1 (fr) 2008-04-29 2010-06-25 Oreal Produit extemporane de soin a base d'un lyophilisat de microorganisme et de tensioactif(s) de hlb superieur ou egal a 12
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US8617537B2 (en) 2008-06-10 2013-12-31 Biogaia Ab Controlled activation of the reuterin-production machinery of lactobacillus
FR2938437B1 (fr) * 2008-11-19 2020-03-27 Société des Produits Nestlé S.A. Utilisation cosmetique de microorganisme pour le traitement des peaux grasses
BRPI0919651A2 (pt) 2008-10-16 2015-08-18 Ganeden Biotech Inc Composições probióticas á base de grãos
BE1018722A5 (nl) * 2009-04-17 2011-07-05 Cruysberghs Rudiger Een biologische samenstelling voor het behandelen van huisdieren en hun levensomgeving.
AU2010242955B2 (en) 2009-04-29 2016-02-04 Ganeden Biotech, Inc. Inactivated bacterial cell formulation
US8506952B2 (en) * 2009-07-03 2013-08-13 James Madison Innovations, Inc. Probiotic compositions and process thereof
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
US8524220B1 (en) 2010-02-09 2013-09-03 David Gordon Bermudes Protease inhibitor: protease sensitivity expression system composition and methods improving the therapeutic activity and specificity of proteins delivered by bacteria
US8771669B1 (en) 2010-02-09 2014-07-08 David Gordon Bermudes Immunization and/or treatment of parasites and infectious agents by live bacteria
WO2011130487A1 (en) 2010-04-14 2011-10-20 Ganeden Biotech, Inc. Probiotic confection and lipid compositions
CN102690764B (zh) * 2010-05-20 2013-07-10 上海交通大学 用于制备l-乳酸的凝结芽孢杆菌及其应用方法
IT1401447B1 (it) * 2010-06-09 2013-07-26 Copan Italia Spa Metodo per il trasferimento quantitativo di analiti
IT1403618B1 (it) 2011-01-05 2013-10-31 Copan Italia Spa Procedimento per realizzare un dispositivo per il prelievo ed il trasferimento di campioni per biologia molecolare
DE102011009798B4 (de) 2011-01-31 2015-03-05 Merz Pharma Gmbh & Co. Kgaa Balneologische lipidhaltige probiotische Zubereitungen für kosmetische / dermatologische / medizinische Anwendungen
CA2827405C (en) 2011-02-15 2023-01-10 Novozymes Biologicals, Inc. Mitigation of odor in cleaning machines and cleaning processes
WO2012135499A1 (en) 2011-03-31 2012-10-04 Ganeden Biotech, Inc. Probiotic sports nutrition compositions
EP2809301A1 (en) 2012-01-31 2014-12-10 Biosoma B.V. Method for administration of a probiotic
US20130251695A1 (en) * 2012-02-28 2013-09-26 Ganeden Biotech, Inc. Cosmetic Compositions
AU2013299605A1 (en) 2012-08-07 2015-03-26 TopGeniX, Inc. Topical composition comprising transformed bacteria expressing a compound of interest
SG10201707532WA (en) * 2013-03-14 2017-10-30 3 In 1 Dental Pllc Compositions For Treatment Of Xerostomia And For Tooth Treatment
BR112015030011A2 (pt) * 2013-05-31 2017-07-25 Univ Cornell composições e métodos para intensificar a germinação
US20150057574A1 (en) 2013-08-23 2015-02-26 Elwha Llc Selecting and Delivering Treatment Agents based on a Microbe Profile
US10010704B2 (en) 2013-08-23 2018-07-03 Elwha Llc Systems, methods, and devices for delivering treatment to a skin surface
US9390312B2 (en) 2013-08-23 2016-07-12 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9456777B2 (en) 2013-08-23 2016-10-04 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US9805171B2 (en) 2013-08-23 2017-10-31 Elwha Llc Modifying a cosmetic product based on a microbe profile
US9811641B2 (en) 2013-08-23 2017-11-07 Elwha Llc Modifying a cosmetic product based on a microbe profile
US9557331B2 (en) 2013-08-23 2017-01-31 Elwha Llc Systems, methods, and devices for assessing microbiota of skin
US10152529B2 (en) 2013-08-23 2018-12-11 Elwha Llc Systems and methods for generating a treatment map
JP6230349B2 (ja) * 2013-09-13 2017-11-15 株式会社ネイチャーサポート 入浴治療用培養液及び培養液循環装置
EP2856896A1 (en) * 2013-09-23 2015-04-08 Life Science TGO, SRL Impregnated odour control products and methods of making the same
US9974311B2 (en) 2013-09-23 2018-05-22 Stewart Group Trading Inc. Impregnated odour control products and methods of making the same
MX376352B (es) 2013-10-25 2025-03-07 Nch Corp Sistema de suministro y composicion probiotica para animales y plantas.
US9596861B2 (en) * 2013-12-24 2017-03-21 Sami Labs Limited Method of producing partially purified extracellular metabolite products from Bacillus coagulans and biological applications thereof
US9737592B1 (en) 2014-02-14 2017-08-22 David Gordon Bermudes Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
US10766799B2 (en) 2014-05-23 2020-09-08 Nch Corporation Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method
WO2015195546A1 (en) 2014-06-17 2015-12-23 TopGeniX, Inc. Topical formulations for uv protection
AU2015308650B2 (en) * 2014-08-29 2018-04-05 Sami Labs Limited Process for enhancing the viable counts of lactic acid bacteria and useful compositions thereof
US10004768B2 (en) 2014-09-25 2018-06-26 Iryohojin Kiyokai Treatment of atopic dermatitis and infectious dermatitis with biological spa therapy
CA2980759A1 (en) 2015-03-31 2016-10-06 Gojo Industries, Inc. Synergistic compositions and methods for mitigating skin irritation and enhancing skin barrier function
US10456435B2 (en) 2015-07-15 2019-10-29 Christopher A. MCELVANY Topical antiviral formulations and methods of using the same
CH711598B1 (de) * 2015-10-16 2017-06-15 Swiss Cream Cosmetics Scc Gmbh Verfahren zur Herstellung von dermatologischen und kosmetischen Präparaten mit ausgeprägten lamellaren Strukturen unter Verwendung von Phosphatidylcholin und Fermentation durch Mikroorganismen.
US20180325117A1 (en) * 2015-10-30 2018-11-15 Zprobiotics Inc. Dba Zbioscience Inc. Probiotic compositions and uses thereof
BE1023416B1 (nl) 2016-02-26 2017-03-14 Chrisal Nv Synbiotisch preparaat
US20170281660A1 (en) * 2016-03-31 2017-10-05 Gojo Industries, Inc. Topical composition for reducing pathogen binding
CA3018866C (en) 2016-03-31 2024-03-26 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
US10806769B2 (en) 2016-03-31 2020-10-20 Gojo Industries, Inc. Antimicrobial peptide stimulating cleansing composition
US10897922B2 (en) 2016-04-05 2021-01-26 Nch Corporation Composition and method for germinative compounds in probiotic food and beverage products for human consumption
PH12018502063B1 (en) 2016-04-05 2024-02-02 Nch Corp Nutrient rich germinant composition and spore incubation method
US12097226B2 (en) 2016-04-05 2024-09-24 Nch Corporation System and method for using a single-serve nutrient spore composition for small scale farm applications
EP3544575A1 (en) 2016-11-23 2019-10-02 GOJO Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
FR3059237B1 (fr) * 2016-11-30 2021-04-30 Nolivade Utilisation d'une composition bacterienne pour traiter des pathologies animales
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
KR102296051B1 (ko) * 2017-06-06 2021-08-31 새미 랩스 리미티드 바실러스 코아귤런스의 세포외 대사물질의 피부 관리 적용
EP3654933A4 (en) * 2017-07-18 2021-05-12 Aobiome LLC AMMONIA OXIDIZING MICROORGANISMS INTENDED FOR USE AND ADMINISTRATION IN THE VISUAL AND HEARING SYSTEMS
US20190060216A1 (en) * 2017-08-31 2019-02-28 Muhammed Majeed Anti-pollution compositions containing bacillus coagulans
EP3678636A4 (en) * 2017-09-07 2021-06-09 Technion Research & Development Foundation Limited Topical kits and compositions and use thereof
WO2019180748A1 (en) * 2018-03-21 2019-09-26 Panjab University Probiotic formulation and uses thereof
US11401500B2 (en) 2018-08-29 2022-08-02 Nch Corporation System, method, and composition for incubating spores for use in aquaculture, agriculture, wastewater, and environmental remediation applications
WO2020097176A1 (en) * 2018-11-06 2020-05-14 Monsanto Technology Llc Processes for treatment of microbe suspensions
AR120973A1 (es) * 2018-11-29 2022-04-06 Rhodia Operations Uso de derivados de guar en composiciones de biofungicidas
EP3685669A1 (en) * 2019-01-23 2020-07-29 Chrisal NV Composition for the decontamination and inoculation of surfaces
WO2020151824A1 (en) * 2019-01-24 2020-07-30 Twe Meulebeke Bvba Dry nonwoven antibacterial article
CN113853198A (zh) 2019-04-09 2021-12-28 德慕拜昂生物科技公司 用于改善皮肤健康和用于治疗和预防与病原微生物相关联的疾病、疾患和病症的组合物和方法
US11576937B2 (en) 2020-02-06 2023-02-14 Nch Corporation Method of reducing gut inflammation reduction in humans by consuming a heated probiotic composition
BE1028228B1 (nl) * 2020-04-22 2021-11-30 Living Tech Cvba Werkwijze voor het verlagen van de werkzame verblijftijd van viruspartikels op oppervlakken en samenstelling hiervoor
FR3110344B1 (fr) * 2020-05-20 2023-12-15 Nolivade Procédé de décontamination
CN113142196A (zh) * 2020-09-04 2021-07-23 江苏省农业科学院 一种解淀粉芽孢杆菌干悬浮剂及其制备方法
CN116635003A (zh) * 2020-12-01 2023-08-22 国际香精香料美国集团有限责任公司 用于皮肤障碍的微生物治疗的方法和组合物
US20250295578A1 (en) * 2020-12-01 2025-09-25 Iff Us Holding, Llc Methods and compositions for microbial treatment of skin disorders
JP2022150437A (ja) * 2021-03-26 2022-10-07 三菱ケミカル株式会社 皮膚状態改善剤及び皮膚粘弾性改善剤
CN115011739B (zh) * 2022-08-03 2022-11-01 南京邦康生物技术有限公司 一种益生菌的生产控制方法与系统
CN115191448B (zh) * 2022-08-12 2023-06-23 宝鸡市烟草公司麟游分公司 防治烟草花叶病毒的微生物植物提取物复合剂及其应用
WO2024062470A1 (en) 2022-09-21 2024-03-28 Moraz Medical Herbs (1989) Ltd. Dermal and cosmetic compositions
CN116064330B (zh) * 2023-01-10 2024-05-03 北京工商大学 凝结芽孢杆菌及其应用
BG113765A (bg) * 2023-08-21 2025-02-28 Иван РАДЕВ Метод за получаване на пробиотичен продукт за неутрализация на алергени, отделяни от акари от домашен прах, състав на продукта и начин на използване

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1285173A (en) * 1968-09-09 1972-08-09 Glaxo Lab Ltd AN alpha-AMYLASE AND A PROCESS FOR ITS PREPARATION
GB1204017A (en) * 1968-10-11 1970-09-03 Sankyo Co Animal feed compositions
US4323651A (en) * 1974-12-04 1982-04-06 R. J. Reynolds Tobacco Company Thermostable lactase derived from bacillus
JPS52102419A (en) * 1976-02-23 1977-08-27 Seikenkai Lactic acid producing bacillus preparation
US4110477A (en) * 1977-05-13 1978-08-29 Kabushiki Kaisha Naruse Fermentation Laboratory Method for producing natto containing lactic acid bacteria
JPS55113718A (en) * 1979-02-27 1980-09-02 Yakult Honsha Co Ltd Antitumor agent
JPS60149527A (ja) * 1984-01-17 1985-08-07 Seikenkai 生体内脱臭剤
US5000939A (en) * 1984-06-12 1991-03-19 Colgate-Palmolive Company Dentifrice containing stabilized enzyme
JPS6396107A (ja) * 1986-10-11 1988-04-27 Shiseido Co Ltd 粉末化粧料
GB8701234D0 (en) * 1987-01-21 1987-02-25 Agricultural Genetics Co Strain of microorganism
US5413960A (en) * 1987-05-01 1995-05-09 Biogaia Ab Antibiotic reuterin
JPH01199575A (ja) * 1988-02-04 1989-08-10 Rikagaku Kenkyusho 新規なサイクロマルトデキストリン・グルカノトランスフェラーゼ及びその製造法
IT1227154B (it) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova Composizioni farmaceutiche per uso ginecologico a base di lattobacilli
AT391323B (de) * 1989-03-10 1990-09-25 Jungbunzlauer Ag Mikroorganismus der species bacillus coagulans sowie ein verfahren zur herstellung von optisch reiner l(+)-milchsaeure
JPH02255620A (ja) * 1989-03-28 1990-10-16 Kazuo Tsubaki 抗白癬菌剤およびその製造方法、利用方法
JPH0367552A (ja) * 1989-05-24 1991-03-22 Toyo Jozo Co Ltd 安定な芽胞形成生菌製剤およびその製造法並びにペレット
US5283059A (en) * 1989-05-24 1994-02-01 Asahi Kasei Kogyo Kabushiki Kaisha Process for producing a stabilized store-forming viable microorganisms preparation containing Bacillus cereus
US5371011A (en) * 1989-07-10 1994-12-06 Zeneca Corp. Mold control in forage
JP2866114B2 (ja) * 1989-09-20 1999-03-08 株式会社資生堂 化粧料
KR920005685B1 (ko) * 1989-11-09 1992-07-13 일동제약 주식회사 유산균을 이용한 항 종양제
US5045314A (en) * 1989-11-14 1991-09-03 The United States Of America As Represented By The Secretary Of Agriculture Control of parasitic nematode ova/larvae with a bacillus laterosporus
DE4001611C1 (enExample) * 1990-01-20 1991-02-28 Skw Trostberg Ag, 8223 Trostberg, De
US5200336A (en) * 1990-07-02 1993-04-06 New England Biolabs, Inc. Restriction endonuclease obtainable foam bacillus coagulans and a process for producing the same
JPH0761255B2 (ja) * 1990-10-31 1995-07-05 旭化成工業株式会社 安定化芽胞形成生菌製剤の製造法
EP0560806A4 (en) * 1990-11-14 1993-11-18 Emu Products Western Australia Pty. Ltd. Anti-inflammatory composition derived from emu oil
CA2037311C (en) * 1990-12-04 1999-04-13 Boyd J. O'donnell Method of inhibiting fungi
IT1262927B (it) * 1992-01-14 1996-07-22 Consiglio Nazionale Ricerche Batteri sporgenti e loro impiego come probiotici
FI92498C (fi) * 1992-06-10 1994-11-25 Valio Meijerien Uusi mikro-organismikanta, sitä sisältävät bakteerivalmisteet ja näiden käyttö hiivojen ja homeiden torjuntaan
WO1994011492A1 (en) * 1992-11-12 1994-05-26 Chr. Hansen's Laboratory, Inc. Method of favorably modifying poultry intestinal microflora
CA2186592C (en) * 1994-03-29 2008-02-19 Helle Outtrup Alkaline bacillus amylase
JPH08175921A (ja) * 1994-12-22 1996-07-09 Idemitsu Kosan Co Ltd 農園芸用殺菌剤組成物
US5728390A (en) * 1995-09-01 1998-03-17 Isp Investments Inc. Cosmetic composition of an alpha or beta-hydroxy acid and a polyvinylpyrrolidone complexing agent
JPH09154535A (ja) * 1995-12-07 1997-06-17 Sanwa Kagaku Kenkyusho Co Ltd 納豆菌含有組成物
US7507402B1 (en) * 1997-04-18 2009-03-24 Ganeden Biotech, Inc. Topical use of probiotic Bacillus spores to prevent or control microbial infections
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
US6716435B1 (en) * 1997-04-18 2004-04-06 Ganeden Biotech, Inc. Absorbent product containing absorbent structure and Bacillus coagulans
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
WO2001013956A2 (en) * 1999-08-26 2001-03-01 Ganeden Biotech, Inc. Use of emu oil a carrier for antifungal, antibacterial, and antiviral medications

Also Published As

Publication number Publication date
EP0975227A1 (en) 2000-02-02
EP0975227B1 (en) 2005-11-09
AU7110298A (en) 1998-11-13
US20110274676A1 (en) 2011-11-10
CA2287451A1 (en) 1998-10-29
AU749001B2 (en) 2002-06-13
JP2009269922A (ja) 2009-11-19
DE69842080D1 (de) 2011-02-10
JP2002512615A (ja) 2002-04-23
CA2287451C (en) 2014-06-10
ES2255730T3 (es) 2006-07-01
EP0975227A4 (en) 2003-05-21
EP1629846A3 (en) 2008-02-27
WO1998047374A1 (en) 1998-10-29
ATE308987T1 (de) 2005-11-15
DE69832267D1 (de) 2005-12-15
EP1629846A2 (en) 2006-03-01
DE69832267T2 (de) 2006-08-10
JP4678896B2 (ja) 2011-04-27
EP1629846B1 (en) 2010-12-29
US20090186057A1 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
ATE308987T1 (de) Oberflächige verwendung von probiotischen bacillussporen zur verhinderung oder bekämpfung von mikrobiellen infektionen
DE69420142D1 (de) Thermoplastische Elastomere Copolymere und diese enthaltendes Haar und Hautflegemittel
DE69421188D1 (de) Thermoplastische und elastomere silikonpfropfcopolymere und diese enthaltende haar- und hautpflegemittel
ATE193025T1 (de) Thermoplastische elastomere copolymere und diese enthaltendes haar- und hautpflegemittel
KR102297406B1 (ko) 피부상재 미생물 조절용 조성물
KR950700720A (ko) 피부 보호 방법 및 그 조성물(Skin Care Method and Composition)
BR9407560A (pt) Copolimeros elastômeros termoplásticos enxertados com silicone e composiçoes para tratamento dos cabelos e da pele contendo estes copolimeros
ATE270558T1 (de) Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
EP1050297A3 (en) Lotionized tissue products containing a pH balance compound for the skin
FR2774588B1 (fr) Composition cosmetique ou dermatologique contenant au moins une proteine de soie d'arachnides naturelle, recombinante ou un analogue
WO1989006649A3 (en) Antibacterial agents
ES2127490T3 (es) Utilizacion de un aceite rico en acido petroselenico como agente hidratante.
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
AU1798995A (en) Use of extracts of filamentous bacteria as cosmetic agents to combat ageing of the skin
TR199900661T2 (xx) Cilt enfeksiyonlar�n�n tedavisi amac�yla 1-hidroksi-2-piridonlar�n kullan�m�
FR2761885B1 (fr) Utilisation d'au moins un extrait d'irvingia gabonensis dans un produit cosmetique et/ou pharmaceutique
ATE307561T1 (de) Verwendung von spezifischen fettstoffen zur modifizierung der physico-chemischen eigenschaften der haut und/oder der schleimhaut als mittel zur verhinderung oder reduzierung der adhäsion von mikro-organismen darauf
EP0402933A3 (en) Use of sucralfate humid gel as vehicle for drugs having topic activity and for cosmetics
JP2015040201A (ja) 化粧料用組成物
CA2214933A1 (en) Herbal salve
MX9705234A (es) Composiciones cosmeticas anhidras con agentes dermatologicamente activos.
MX9708385A (es) Derivados novedosos de tetraciclina, composiciones que los contienen, y el uso de las mismas.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties